In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

Published Date: 20 Mar 2024

Breast cancer that manifests in between two screening program reviews is known as interval breast cancer. In other words, a negative test result precedes the next evaluation and the diagnosis is made after that. It is very trustworthy for obvious reasons.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types

2.

The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.

3.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

4.

Reducing social media to an hour a day boosts young people's self-image.

5.

Charles III, King of Kings, is Cancerous.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot